Geoff Meyerson didn’t just choose a career—he built one. From investment banking and venture capital to launching Locust Walk the day Lehman Brothers collapsed, Geoff shares how betting on himself led to a 17-year nonlinear journey at the center of biotech dealmaking. This episode dives into what it really means to “zig when others zag,” why Boston still matters (but isn’t untouchable), and how China has become impossible to ignore in global biotech.

Along the way, Geoff breaks down the evolving role of AI in life sciences, what actually matters when hiring (hint: it’s not your degree), and why showing up—physically and consistently—is still the ultimate competitive advantage. The conversation weaves between business, family, and the realities of building something from scratch, with plenty of humor about everything from packing strategies to performance reviews…including giving one to your own mom.